You Are Here :
Advanced formulation destined to mature women (peri-menopause and menopause women). Able to alleviate the discomfort related to hormonal deficiencies.
Goro Healthcare partners with Demophorius in the UAE and Qatar
Goro Healthcare launches Neopausil® in the United Arab Emirates
Tanyx® obtain MOHAP registration approval
Goro Healthcare signs an exclusive distribution agreement with The OTClab and Perfect Care Phamra
Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response
FDA announces first of its kind program to communicate patient reported outcomes from oncology clinical trials